Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US
18 avr. 2018 08h30 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., April 18, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics Announces Coverage of Its Thyroid Assays by Blue Shield of California
02 avr. 2018 08h30 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Announces Agreement with Acupath Laboratories
28 mars 2018 08h30 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) --
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company...
Interpace Diagnostics Announces Expansion of LabCorp National Agreement
20 mars 2018 08h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2017 Financial Results, Business Progress Against Plan and Recent Accomplishments
15 mars 2018 16h01 HE
|
Interpace Diagnostics Group, Inc.
Revenue for the Quarter Grew 40% over the Comparable Prior Year Quarter and 21% for the Full Year, Raising $30 Million in Equity and Significantly Improving Balance Sheet and Cash Position,...
Interpace Diagnostics Announces Timing of Earnings Release and Investor Conference Call
14 mars 2018 14h30 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 14, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (the “Company”), a fully integrated commercial and bioinformatics company that provides...
Interpace Diagnostics Announces Additional Coverage of Thyroid Tests
08 mars 2018 08h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Horizon Blue Cross Blue Shield of New Jersey to Cover Interpace’s Molecular Thyroid Tests
26 févr. 2018 08h30 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report
22 févr. 2018 13h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...
Interpace Diagnostics to Present Data on Thyroid, Pancreatic, and Lung Assays
12 févr. 2018 09h00 HE
|
Interpace Diagnostics Group, Inc.
PARSIPPANY, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that...